Ipilimumab-induced renal granulomatous arteritis: a case report
Authors:
- Mathilde LemoineMLMathilde Lemoine
- Baptiste DillyBDBaptiste Dilly
- Alexandre CurieACAlexandre Curie
- Vivien HébertVHVivien Hébert
- Charlotte LaurentCLCharlotte Laurent
- Mélanie HanoyMHMélanie Hanoy
- Steven GrangéSGSteven Grangé
- Dominique GuerrotDGDominique Guerrot
- Arnaud FrançoisAFArnaud François
- Dominique BertrandDBDominique Bertrand
Open Access
- 11 October 2019
- journal article
- case report
- Published by Springer Nature in BMC Nephrology
- Vol. 20 (1) , 1-5
Abstract
Background: Immune Checkpoint Inhibitors (ICPIs) are promising new drugs in treatment of advanced tumours targeting cytotoxic T-lymphocyte antigen-4 (CTLA-4) and programmed cell death protein-1 (PD1) or its ligand (PDL-1). Ipilimumab is a monoclonal antibody targeting the CTLA-4 receptor used in treatment of metastatic melanoma. By increasing activity of the immune system, ICPIs lead to immune-related adverse events, such as dermatitis, colitis or hepatitis. ICPIs-related kidney adverse events are rare and acute tubulointerstitial nephritis with or without granuloma have mainly been reported. Case presentation: We report a case of acute kidney injury in a patient with melanoma treated by ipilimumab. Kidney biopsy revealed acute interlobular and juxtaglomerular granulomatous arteritis, which has not yet been reported in patients treated by ICPIs. Kidney function partially recovered after ipilimumab discontinuation and oral prednisone. Unfortunately, the patient died a few months later from progression of his melanoma. Conclusion: This case highlights a new mechanism of acute kidney injury related to ICPIs and supports the interest of kidney biopsy in case of ICPIs related acute renal failure.Keywords
This publication has 17 references indexed in Scilit:
- Nephrotic Syndrome With Cancer Immunotherapies: A Report of 2 CasesAmerican Journal of Kidney Diseases, 2017
- Glomerulonephritis and granulomatous vasculitis in kidney as a complication of the use of BRAF and MEK inhibitors in the treatment of metastatic melanomaMedicine, 2017
- Renal effects of immune checkpoint inhibitorsNephrology Dialysis Transplantation, 2016
- Association of Acute Interstitial Nephritis With Programmed Cell Death 1 Inhibitor Therapy in Lung Cancer PatientsAmerican Journal of Kidney Diseases, 2016
- Adverse Events Associated with Immune Checkpoint Blockade in Patients with Cancer: A Systematic Review of Case ReportsPLOS ONE, 2016
- Kidney involvement in medium- and large-vessel vasculitisJournal Of Nephrology, 2016
- Kidney injuries related to ipilimumabInvestigational New Drugs, 2014
- Drug‐Associated Polymyalgia Rheumatica/Giant Cell Arteritis Occurring in Two Patients After Treatment With Ipilimumab, an Antagonist of CTLA‐4Arthritis & Rheumatology, 2014
- Renal Sarcoidosis Presenting as Acute Kidney Injury With Granulomatous Interstitial Nephritis and VasculitisAmerican Journal of Kidney Diseases, 2012
- CT60 and +49 polymorphisms of CTLA 4 are associated with ANCA-positive small vessel vasculitisRheumatology, 2009